Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
85.95 USD | +0.21% | -0.33% | +20.19% |
13/05 | Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing | MT |
08/05 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.19% | 1.54B | |
+33.21% | 709B | |
+30.77% | 595B | |
-1.98% | 367B | |
+20.16% | 334B | |
+5.20% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.35% | 171B |
- Stock Market
- Equities
- LGND Stock
- News Ligand Pharmaceuticals Incorporated
- Ligand Pharmaceuticals Incorporated : Craig-Hallum Adjusts Price Target on Ligand Pharmaceuticals to $215 From $195, Reiterates Buy Rating